PHARMAGENIC ENRICHMENT Trademark

Trademark Overview


On Wednesday, January 17, 2024, a trademark application was filed for PHARMAGENIC ENRICHMENT with the United States Patent and Trademark Office. The USPTO has given the PHARMAGENIC ENRICHMENT trademark a serial number of 79389202. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, February 4, 2025. This trademark is owned by PolygenRx Pty Ltd. The PHARMAGENIC ENRICHMENT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Advisory services relating to pharmaceutical products, namely, providing information to patients in the field of administering medication; provision of pharmaceutical medical information; genetic testing for medical purposes; medical advisory services relating to medical problems; medical advisory services relating to medical services; alternative medical services; arranging of medical treatment, namely, providing medical treatment of chronic diseases in the nature of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; cardiology medical services; complementary medical services; conducting of medical examinations; general practice (GP) medical services; fitness testing, namely, medical testing for fitness evaluation; gastroenterology medical services; endocrinology medical services; dietetic counselling services, namely, dietic advisory services; medical consultancy ...

General Information


Serial Number79389202
Word MarkPHARMAGENIC ENRICHMENT
Filing DateWednesday, January 17, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAdvisory services relating to pharmaceutical products, namely, providing information to patients in the field of administering medication; provision of pharmaceutical medical information; genetic testing for medical purposes; medical advisory services relating to medical problems; medical advisory services relating to medical services; alternative medical services; arranging of medical treatment, namely, providing medical treatment of chronic diseases in the nature of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; cardiology medical services; complementary medical services; conducting of medical examinations; general practice (GP) medical services; fitness testing, namely, medical testing for fitness evaluation; gastroenterology medical services; endocrinology medical services; dietetic counselling services, namely, dietic advisory services; medical consultancy and advisory services in relation to medical services; medical analysis of tissues for medical treatment for persons; health care consultancy services; health farm services in the nature of health spa services for health and wellness of the body and spirit offered at a health club facility; medical advice for individuals with disabilities; medical advisory services; medical analysis services relating to the treatment of patients; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis and treatment of persons; medical assistance; medical care services; medical clinic services; medical consulting services relating to offshore medical services; medical counselling; medical diagnostic services; medical examination of individuals; medical health assessment services; medical services in the field of oncology; medical screening; medical services; medical treatment services, namely, medical treatment of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; medical treatment using cultured cells; neurology medical services; oncology medical services; ophthalmology medical services; pediatric medical services; preparation of reports relating to medical matters in the nature of providing medical information to patients, medical professionals, medical providers, pharmacists, pathologists, pathology service providers, medical payers, including public and private health insurers, medical device distributors, pharmaceutical distributors, and biotechnology companies in the form of reports in the field of complex traits and disorders relating to cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases, including pharmaceutical-gene interactions, and predictions of the magnitude of response to treatments and interventions; providing medical information including online, about medical services; provision of medical assistance; provision of medical facilities, namely, leasing of equipped medical facilities that medical professionals can use on an as-needed basis; provision of medical information; provision of medical services; provision of medical treatment of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; services for the preparation of medical reports in the nature of providing medical information to patients, medical professionals, medical providers, pharmacists, pathologists, pathology service providers, medical payers, including public and private health insurers, medical device distributors, pharmaceutical distributors, and biotechnology companies in the form of reports in the field of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePolygenRx Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Friday, February 16, 2024APPLICATION FILING RECEIPT MAILED
Friday, August 16, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 10, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 30, 2024ASSIGNED TO EXAMINER
Wednesday, August 7, 2024NON-FINAL ACTION WRITTEN
Thursday, August 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 16, 2024REFUSAL PROCESSED BY MPU
Tuesday, February 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 8, 2024REFUSAL PROCESSED BY IB